Avita's ReCell meets in pivotal trial for third-degree burns

Avita Medical Ltd. (ASX:AVH; OTCQX:AVMXY) said ReCell met the co-primary endpoints in a pivotal trial to treat deep full-thickness (third-degree) burns. ReCell is a

Read the full 240 word article

User Sign In